Dominic Piscitelli
2017 - ANAPTYSBIO
In 2017, Dominic Piscitelli earned a total compensation of $2.9M as Chief Financial Officer at ANAPTYSBIO.
Compensation breakdown
| Bonus | $111,143 |
|---|---|
| Option Awards | $2,290,041 |
| Salary | $356,811 |
| Other | $113,253 |
| Total | $2,871,248 |
Piscitelli received $2.3M in option awards, accounting for 80% of the total pay in 2017.
Piscitelli also received $111.1K in bonus, $356.8K in salary and $113.3K in other compensation.
Rankings
In 2017, Dominic Piscitelli's compensation ranked 3,801st out of 14,666 executives tracked by ExecPay. In other words, Piscitelli earned more than 74.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,801 out of 14,666 | 74th |
Division Manufacturing | 1,323 out of 5,772 | 77th |
Major group Chemicals And Allied Products | 371 out of 2,075 | 82nd |
Industry group Drugs | 286 out of 1,731 | 84th |
Industry Pharmaceutical Preparations | 227 out of 1,333 | 83rd |
Source: SEC filing on April 26, 2018.
Piscitelli's colleagues
We found three more compensation records of executives who worked with Dominic Piscitelli at ANAPTYSBIO in 2017.
News
Oric Pharmaceuticals CEO Jacob Chacko's 2023 pay falls 28% to $3.2M
April 24, 2024
Oric Pharmaceuticals CEO Jacob Chacko's 2022 pay falls 37% to $4.4M
April 26, 2023
Oric Pharmaceuticals CEO Jacob Chacko's 2021 pay rises 19% to $7M
April 27, 2022
Oric Pharmaceuticals CEO Jacob Chacko's 2020 pay jumps 774% to $5.9M
April 26, 2021
ANAPTYSBIO CEO Hamza Suria's 2019 pay jumps 54% to $7.9M
April 27, 2020
ANAPTYSBIO CEO Hamza Suria's 2018 pay jumps 28% to $5.1M
April 26, 2019